Niagen Bioscience (NAGE) Short term Debt (2016 - 2018)

Niagen Bioscience (NAGE) has 3 years of Short term Debt data on file, last reported at $137000.0 in Q4 2018.

• On a quarterly basis, Short term Debt fell 55.81% year-over-year to $137000.0 in Q4 2018; TTM through Dec 2018 was $137000.0, a 55.81% decrease from a year earlier, with the FY2018 full-year figure at $137000.0, down 55.81% from the prior year.
• Short term Debt for Q4 2018 stood at $137000.0, down from $310000.0 in the prior quarter.
• Over the last five years, Short term Debt for NAGE reached as high as $1.5 million in Q1 2016 and fell as low as $137000.0 in Q4 2018.
• Historically, Short term Debt has averaged $579894.5 across 3 years, with a median of $327000.0 in 2016.
• Across the five-year window, Short term Debt plunged 77.5% in 2016 and fell 9.88% in 2017, its largest moves.
• Year by year, Short term Debt stood at $344000.0 in 2016, then slipped by 9.88% to $310000.0 in 2017, then tumbled by 55.81% to $137000.0 in 2018.
• Per Business Quant data, the three most recent Short term Debt figures were $137000.0 in Q4 2018, $310000.0 in Q4 2017, and $344000.0 in Q4 2016.